A carregar...
No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty: A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial
BACKGROUND AND PURPOSE: We have previously shown that during the first 2 years after total hip arthroplasty (THA), periprosthetic bone resorption can be prevented by 6 months of risedronate therapy. This follow-up study investigated this effect at 4 years. PATIENTS AND METHODS: A single-center, doub...
Na minha lista:
| Publicado no: | Acta Orthop |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Informa Healthcare
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4564779/ https://ncbi.nlm.nih.gov/pubmed/25885280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/17453674.2015.1041846 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|